Fight the Anti-Vaccination Movement With Marketing Dollars

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

GlaxoSmithKline (NYSE: GSK  ) announced last week that it's seeking approval for the first-ever malaria vaccine. The news is remarkable for two very different reasons. It's the first vaccine to show any real effectiveness against the global scourge of malaria, which kills an estimated 600,000 people a year — most of them children.

A woman in Papua New Guinea gets the MMR vaccine. Photo: US Navy

GSK's breakthrough also highlights a curious discrepancy. Its malaria vaccine is being welcomed by African health officials even though it only offers a 25%-50% efficacy rate. Across the Atlantic in the U.S., growing numbers of consumers are forgoing vaccines that are far more effective against diseases including whooping cough and measles, and communities around the country are seeing outbreaks as a result.

Better access won't solve the problem

Part of the issue stems from poverty and inadequate health care access. Families living in poverty are less likely to have fully immunized kids. In states with their own health care exchanges and expanded Medicaid, the barriers of cost and access will fall in January, because immunizations will be free under the new law.

But in the 21 states that haven't expanded Medicaid, an estimated 7 million poor Americans will fall into a gap that disqualifies them from Medicaid without qualifying them for ACA subsidies. It's unclear how many of those people will be able to keep up with the recommended immunization schedule through schools and free clinics.

The other group that's not following vaccine guidelines for measles and whooping cough is parents in communities where there's mistrust of modern medicine and/or the government. Obamacare won't affect their choices. They're opting out based on information from discredited researchers like Andrew Wakefield, unqualified celebrities and conspiracy theorists.

It's tempting to dismiss these parents as outliers, but they are outspoken to the point that some parents feel intimidated to say they support vaccines, and their choices are causing outbreaks like the huge whooping cough surge in California in 2010 that killed 10 infants and sickened 9,000 people, as well as last month's north Texas measles outbreak.

What's in it for parents?

Consumers always ask what's in it for them, and modern parents tend to research every step of the child-rearing journey. Vaccine makers and public health agencies have left a void in the American conversation where a compelling description of vaccine benefits should be, and anti-vaccine advocates have filled that gap with scary claims about what could happen if you vaccinate your child. There are risks associated with vaccines, such as allergic reactions, but the notion that vaccines cause autism has been thoroughly debunked.

The benefits of immunizations should be obvious. But so should the benefits of eating right and exercising, and we still hear about them every day. We live in a society where the absence of vaccine-preventable disease has rendered shot benefits invisible — until someone brings home measles from abroad and shares it with the unvaccinated members of his congregation.

Dry reports from an epidemiological perspective don't speak to the mother who's heard erroneous claims that the MMR shot could give her son autism. Vaccination campaigns aimed at parents of newborns don't click with parents of tweens and teens, who still need boosters. (Full disclosure: I used to worry about thimerosal in vaccines and delayed some of my oldest child's shots with my doctor's input. These days we follow the schedule to the letter.)

Smart marketing can make shots matter

Parents and the rest of us should be reminded of three main upsides to a robust vaccine program. The first and most obvious is reduced risk of illness and death — an unfortunately hard case to make when most of us have never met anyone who survived smallpox or spent time in an iron lung.

For parents who are convinced they're doing right by their kids by opting out, and for adults who mistakenly think their childhood shots still protect them, an appeal based on the next benefit could have an impact: Keeping herd immunity high (a 95% vaccine rate for pertussis, for example) protects our most vulnerable people. Babies too young for shots, children and adults undergoing cancer treatment, pregnant women, and others with valid medical reasons to opt out depend on the rest of us to keep group immunity high.

Sanofi Pasteur (NYSE: SNY  ) and the March of Dimes take this approach with their Sounds of Pertussis campaign. Actress Sarah Michelle Gellar talks about the risks that unvaccinated adults pose to newborns and urges parents, grandparents and caregivers to get pertussis boosters. The campaign is a compelling reminder to adults that their health affects the babies in their lives.

Not everyone knows a newborn, though. A campaign featuring older children and adults who rely on herd immunity would put a sympathetic human face on the risks of skipping vaccines and spark a conversation about our individual responsibility toward sick people, even if they're total strangers. Our personal vaccine choices can be as much of a public-health contribution as donating blood or joining the bone-marrow donor registry.

If protecting their children and vulnerable members of society doesn't get vaccine holdouts to take action, it's worth reminding people of the hassle and expense of illnesses like measles and whooping cough: lost work and school days, child care problems, hospitalization, and in some cases follow-up therapy. In other words, "Your child might not ever get whooping cough but if she does, here's how it's going to turn your life upside down."

Here in the U.S. we have the tools to keep measles, whooping cough, and other nasty infections in check, and we are so lucky that we don't have to think about protecting our kids from malaria each and every day. What we need now is a healthy dose of smart marketing from pharmaceutical companies and public health groups to remind us of exactly what's in that syringe for us.

Getting inside Obamacare

Obamacare is rewriting the rules for the health care industry, and in the process of doing so, it's creating massive opportunities for investors to get ridiculously rich. How? By investing in a handful of specific health care stocks. In this free report, our analysts walk you through these opportunities and the companies that are positioned to exploit them. The informational edge contained in it is invaluable, but can only be exploited profitably while the rest of the market remains in the dark. To access this free report instantly, simply click here now.

Read/Post Comments (5) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 15, 2013, at 5:27 PM, mpmiller37 wrote:

    Why is it that I have to hear liberal foolish opinions that support the government and pharmaceutical money machines that attempt to force vaccination because "THEY" know what's best for me and my kids. Give me a freaking break and stick to the financials.

  • Report this Comment On October 15, 2013, at 6:54 PM, cmalek wrote:

    "But in the 21 states that haven't expanded Medicaid, an estimated 7 million poor Americans will fall into a gap that disqualifies them from Medicaid without qualifying them for ACA subsidies."

    Wasn't Obamacare supposed to provide UNIVERSAL coverage?! 7 million without coverage sure does not sound universal.

  • Report this Comment On October 15, 2013, at 8:04 PM, lwbaum wrote:

    Thanks for this article about an important and under-discussed topic. True, it's not directly about investing, but it's about life and death, which is sometimes worth thinking about in addition to money.

  • Report this Comment On October 16, 2013, at 3:09 AM, Locrow wrote:

    Casey, I missed the MD behind your name. The claims that you are so brazenly making in this "investing" article are astounding. Possibly your position on vaccines when your children were younger saved you from a plethora of problems. Immunizing infants as we do in the US with so many vaccines at such ay young age - months old - certainly does effect an individual's auto immune system.

    Medicine is not a science it is an art form and one size does not fit all. But as you suggest, I'm sure there will be plenty of marketing dollars thrown at it to convince the population that business people like you have all the answers.

    I am really disappointed in this article and as a Fool reader for many years have never found another one quite like this. It is one thing to comment on financial implications it is entirely another to state public health policy and medical conclusions.

    Best if luck to you Fools!!

  • Report this Comment On October 16, 2013, at 12:01 PM, akyra wrote:

    My medical doctor advises against getting vaccines unless they are absolutely necessary because he feels it weakens the immune system.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2676849, ~/Articles/ArticleHandler.aspx, 9/29/2016 11:33:12 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 hours ago Sponsored by:
DOW 18,143.45 -195.79 -1.07%
S&P 500 2,151.13 -20.24 -0.93%
NASD 5,269.15 -49.39 -0.93%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 4:02 PM
GSK $42.90 Down -0.77 -1.76%
GlaxoSmithKline CAPS Rating: ***
SNY $37.83 Down -0.84 -2.17%
Sanofi CAPS Rating: *****